348 related articles for article (PubMed ID: 26289575)
1. Fluorescence anisotropy (polarization): from drug screening to precision medicine.
Zhang H; Wu Q; Berezin MY
Expert Opin Drug Discov; 2015; 10(11):1145-61. PubMed ID: 26289575
[TBL] [Abstract][Full Text] [Related]
2. Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade.
Deacon M; Singleton D; Szalkai N; Pasieczny R; Peacock C; Price D; Boyd J; Boyd H; Steidl-Nichols JV; Williams C
J Pharmacol Toxicol Methods; 2007; 55(3):238-47. PubMed ID: 17141530
[TBL] [Abstract][Full Text] [Related]
3. Ligand Discovery: High-Throughput Binding: Fluorescence Polarization (Anisotropy).
Holdgate GA; Hemsley PE
Methods Mol Biol; 2021; 2263():231-246. PubMed ID: 33877601
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer.
Owicki JC
J Biomol Screen; 2000 Oct; 5(5):297-306. PubMed ID: 11080688
[TBL] [Abstract][Full Text] [Related]
5. Functional protein micropatterning for drug design and discovery.
You C; Piehler J
Expert Opin Drug Discov; 2016; 11(1):105-19. PubMed ID: 26624534
[TBL] [Abstract][Full Text] [Related]
6. Application of Fluorescence Polarization in HTS Assays.
Huang X; Aulabaugh A
Methods Mol Biol; 2016; 1439():115-30. PubMed ID: 27316991
[TBL] [Abstract][Full Text] [Related]
7. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
McGivern JV; Ebert AD
Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
[TBL] [Abstract][Full Text] [Related]
8. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
Donato MT; Gómez-Lechón MJ; Tolosa L
Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
[TBL] [Abstract][Full Text] [Related]
9. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
10. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
Tsaioun K; Jacewicz M
Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous fluorescence anisotropy-based assay for characterization of ligand binding dynamics to GPCRs in budded baculoviruses: the case of Cy3B-NDP-α-MSH binding to MC4 receptors.
Veiksina S; Kopanchuk S; Mazina O; Link R; Lille A; Rinken A
Methods Mol Biol; 2015; 1272():37-50. PubMed ID: 25563175
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.
McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST
J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence anisotropy and resonance energy transfer: powerful tools for measuring real time protein dynamics in a physiological environment.
Yengo CM; Berger CL
Curr Opin Pharmacol; 2010 Dec; 10(6):731-7. PubMed ID: 20971683
[TBL] [Abstract][Full Text] [Related]
14. Development and application of PI3K assays for novel drug discovery.
Yanamandra M; Mitra S; Giri A
Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence polarization assays in high-throughput screening and drug discovery: a review.
Hall MD; Yasgar A; Peryea T; Braisted JC; Jadhav A; Simeonov A; Coussens NP
Methods Appl Fluoresc; 2016 Apr; 4(2):022001. PubMed ID: 28809163
[TBL] [Abstract][Full Text] [Related]
16. Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach.
Piper DR; Duff SR; Eliason HC; Frazee WJ; Frey EA; Fuerstenau-Sharp M; Jachec C; Marks BD; Pollok BA; Shekhani MS; Thompson DV; Whitney P; Vogel KW; Hess SD
Assay Drug Dev Technol; 2008 Apr; 6(2):213-23. PubMed ID: 18471075
[TBL] [Abstract][Full Text] [Related]
17. Development and application of fluorescence polarization assays in drug discovery.
Burke TJ; Loniello KR; Beebe JA; Ervin KM
Comb Chem High Throughput Screen; 2003 May; 6(3):183-94. PubMed ID: 12678697
[TBL] [Abstract][Full Text] [Related]
18. Development of a high-throughput fluorescence polarization assay for the discovery of phosphopantetheinyl transferase inhibitors.
Duckworth BP; Aldrich CC
Anal Biochem; 2010 Aug; 403(1-2):13-9. PubMed ID: 20382102
[TBL] [Abstract][Full Text] [Related]
19. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
20. Application of fluorescence polarization in HTS assays.
Huang X; Aulabaugh A
Methods Mol Biol; 2009; 565():127-43. PubMed ID: 19551360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
